Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin.
Falini B, Bolognesi A, Flenghi L, Tazzari PL, Broe MK, Stein H, Dürkop H, Aversa F, Corneli P, Pizzolo G, et al.
Falini B, et al. Among authors: flenghi l.
Lancet. 1992 May 16;339(8803):1195-6. doi: 10.1016/0140-6736(92)91135-u.
Lancet. 1992.
PMID: 1349939